GSK to Invest Over $800 Million to Expand Pennsylvania Manufacturing

Key Facts

GSK announced an investment of over $800 million to expand its manufacturing presence in Pennsylvania, USA. Seeking Alpha reported that the capital commitment is directed toward boosting operations in Montgomery County, a move expected to create approximately 300 jobs over the next five years.

The investment aims to modernize and expand the company's manufacturing footprint to support its drug pipeline and global supply chain. GSK currently employs around 4,500 full-time staff in the region and is focusing on increasing production capacity through this facility expansion.